Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4 | 9 | 452 | 1 | 2 |
| Receivables | 37 | 19 | 38 | 16 | 20 |
| TOTAL | $76 | $45 | $520 | $36 | $47 |
| Non-Current Assets | |||||
| PPE Net | 257 | 286 | 328 | 370 | 417 |
| Intangibles | 852 | 870 | 889 | 908 | 926 |
| Other Non-Current Assets | 22 | 22 | 22 | 105 | 34 |
| TOTAL | $1,130 | $1,178 | $1,239 | $1,382 | $1,377 |
| Total Assets | $1,206 | $1,223 | $1,759 | $1,419 | $1,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,277 | 2,386 | 2,455 | 2,718 | 2,467 |
| Accrued Expenses | 2,667 | 2,467 | 2,215 | 2,343 | 2,094 |
| Other current liabilities | 1,277 | 278 | 216 | 111 | N/A |
| TOTAL | $10,648 | $8,824 | $8,353 | $8,045 | $6,994 |
| Non-Current Liabilities | |||||
| Long Term Debt | 407 | 84 | 194 | 62 | 120 |
| Other Non-Current Liabilities | 19 | 5 | 48 | 2 | 24 |
| TOTAL | $426 | $90 | $242 | $64 | $145 |
| Total Liabilities | $11,074 | $8,914 | $8,595 | $8,109 | $7,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 2 | 2 | 2 |
| Common Shares | 7 | 7 | 6 | 6 | 6 |
| Retained earnings | -57,427 | -53,912 | -51,405 | -49,545 | -47,493 |
| TOTAL | $-9,868 | $-7,690 | $-6,837 | $-6,690 | $-5,715 |
| Total Liabilities And Equity | $1,206 | $1,223 | $1,759 | $1,419 | $1,424 |